Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Cell and gene therapy 3

Cell and Gene Therapy

Intellia's Quest with CRISPR; Innovent, Synaffix ADC Tech Deal; Lilly's Diabetes Blockbuster Tirzepatide; Polyphor’s Bleak Future

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Intellia’s Quest with CRISPR; Innovent, Synaffix ADC Tech Deal; Lilly’s Diabetes Blockbuster Tirzepatide; Polyphor’s Bleak Future

A New Dawn for CRISPR, Intellia Edits Cells Inside the Body Intellia Therapeutics, along with its partner Regeneron Pharmaceuticals, recently announced its successful attempt in editing the cells inside the body leveraging the CRISPR technique. The world’s first-ever trial that has their DNA edited through an in vivo CRISPR/Cas9 therapy brought good news for everyone as the trials managed to present improvements in a rare inherited liver disorder. The robust efficacy data was coupled with an encouraging safety profile with no serious adverse events as observed in the first six patients as of day 28. The treatment aims to repair a gene responsible for transthyret...

Explore More...

recent-pharma-happenings-for-amylyx-orca-lyell-ionis

Amylyx’s neuron-protecting drug slows ALS decline; Antisense drugs could help fight ALS and dementia; CAR-T research updates; Orca and Lyell announces research partnership

pharma-news-updates-for-biomarin-gilead-alzheon

FDA rejects BioMarin’s Valoctocogene Roxaparvovec; J&J inks $6.5B deal; Alzheon bags $47M; Research updates on diabetes

pharma-news

Startup focuses tumors with CAR-T; AbCellera grabs USD 105M; Gilead inks USD 2B deal; GSK’s anti-BCMA antibody receives a boost

pharma-news

CanSino deals with Precision; Atea raises USD 215 M; Applied Molecular Transport targets for USD 100 M IPO; Cell therapy repairs multiple sclerosis in mice

CAR-T cell therapy market for Non-Hodgkin lymphoma

CAR-T cell therapy market for Non-Hodgkin lymphoma: Future prospects, and untapped opportunities

CAR-T Cell Therapy Market In ALL- Acute lymphocytic leukemia

Future Perspectives Of CAR-T Cell Therapy Market In Acute Lymphoblastic Leukemia (ALL)

Pharma News

CAR-T in killing tumors; Amunix raises $73M; Autism findings in protein-targeted treatment

cocaine addiction

Gene therapy might make cocaine less addictive

Car-TCR Summit Europe 2020

Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?

Curing HIV with gene therapy

In a blind race to cure HIV, can Gene therapy be a deal-breaker?

Autologous cell therapy market

Autologous cell therapy market: A new paradigm for kidney diseases

Japan's regenerative medicine

Japan is transforming its Healthcare sector through Regenerative Medicine

Pharma News

Zogenix acquires Modis Therapeutics; Amgen buys Otezla; CRISPR slows down the Breast cancer rate

Recent Pharma News

Notizia

Notizia

HealthPNX

Notizia

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly